Basic criteria for manuscripts submitted to APJTM


To comply with existing Wolters Kluwer policies & the Principles of Transparency and Best Practice in Scholarly Publishing and ensure the high-quality, fair and ethical publication of scientific papers, APJTM is committed to meeting and upholding standards of ethical behavior at all stages of the publication process. We follow closely the industry associations, such as the Committee on Publication Ethics (COPE), International Committee of Medical Journal Editors (ICMJE) and World Association of Medical Editors (WAME), that set standards and provide guidelines for best practices in order to meet these requirements.

For a summary of our specific policies regarding duplicate publication, conflicts of interest, patient consent, etc., please visit www.Medknow.com/EthicalGuidelines.asp

Manuscript is considered for publication in APJTM on the understanding that all authors obeyed the following Basic Criteria:

  • Obscured facial photos of human subjects:Patients have a right to privacy that should not be violated without informed consent. Identifying information, including names, initials, or hospital numbers, should not be published in written descriptions, photographs, or pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication.  
  • IRB approval and/or Informed consent statements in all articles:All articles dealing with original human or animal data must include a statement on ethics approval at the beginning of the Methods section and must have been conducted according to the principles expressed in the Declaration of Helsinki. This paragraph must contain the following information: the name and address of the ethics committee responsible; the protocol number that was attributed by this ethics committee; and the date of approval by the ethics committee.
  • Protocol number & Date of approval by Clinical trial registration: It is required, and recommended the registration of clinical trials in a public trials registry at or before the time of first patient enrollment as a condition of consideration for publication.
  • Conclusions backed by current literature: Conclusions should be made based on discussion and comparison with current literature.
  • Good writing quality: Overall writing quality should not be so poor that it is difficult to understand the material in many articles. 
  • Detailed Materials and Methods for reproducibility: To improve the reproducibility of published research articles, authors are urged to provide additional important details about their reported studies. These details include: identifiers for the reagents and tools used in the study, step-by-step protocols, and software code. At this point in time, addition of this information is strongly encouraged, but not required.
  • Rigorous statistical analyses